Aberdeen Group’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.3M Buy
896,594
+416,225
+87% +$6.16M 0.02% 534
2025
Q1
$8.61M Buy
480,369
+88,369
+23% +$1.58M 0.02% 594
2024
Q4
$6.83M Buy
+392,000
New +$6.83M 0.01% 588